Significant Muscle Loss New research suggests that up to 60% of weight lost on GLP-1 drugs comes from lean muscle mass, which slows metabolism and makes long-term weight maintenance harder
Small vials suit a 0.25 to 0.5 mg start or a taper
Worse, repeated cortisone injections can actually weaken tendons and cartilage over time
While GLP-1 medications don't come with a universal playbook for stopping them, experts generally discourage quitting without a plan
Due to the high costs, however, GLP-1 coverage for obesity treatment in Medicaid (as well as ACA Marketplace plans and most large employer firms) remains limited: To view or add a comment, sign in More Relevant Posts Among Medicaid patients with #OpioidUseDisorder at US opioid treatment programs, 30-, 90-, and 180-day retention rates were low and variable, highlighting opportunities for quality improvement in program performance